IOLCP212.00

IOL Chemicals and Pharmaceuticals Limited

· Pharma & Health
₹ CrorePeersMOREPENLABFDCINNOVACAPORCHPHARMASENORESSANOFIGUJTHEMRPGLIFEMcap ₹6,223 Cr
View
In ₹ Crore except Per Share
12 Months Ending
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Adjustments to Reconcile Profit — Non-cash Items
+ Depreciation & Amortisation62.972.080.2
+ Finance Costs16.114.814.6
+ Interest Income-14.0-10.6-13.3
+ Fair Value (Gains) / Losses-0.00.00.0
+ Unrealised FX (Gain) / Loss0.03.93.0
+ Other Non-cash Items0.0-0.20.6
+ Other Reconciling Items-4.90.00.0
Changes in Working Capital
+ Inventories-99.364.2-10.5
+ Trade Receivables — Current27.7-39.0-73.5
+ Other Current Assets162.00.00.0
+ Trade Payables — Current0.0-46.166.7
Cash from Operating Activities
Profit Before Tax (per I/S)181.7138.0184.4225.5
+ Total Adjustments (incl. Working Capital)150.559.067.8
Cash from Operations (pre-tax)332.1196.9252.2
+ Income Taxes Paid42.018.337.9
Cash from Operating Activities290.1178.6214.3
Cash from Investing Activities
+ Acq of Fixed Assets (Capex)274.2213.6173.0
+ Disp of Fixed Assets1.91.02.1
+ Acq of Investment Property0.50.00.0
+ Disp of Investment Property0.20.00.0
+ Interest Received — Investing13.512.311.6
+ Other Inflows / (Outflows) — Investing67.946.1-38.8
Cash from Investing Activities-191.3-154.2-198.1
Cash from Financing Activities
+ Proceeds from Borrowings0.084.315.0
+ Repayment of Borrowings46.90.00.0
+ Payment of Lease Liabilities0.20.00.0
+ Interest Paid16.114.814.5
+ Dividends Paid29.423.529.4
+ Other Inflows / (Outflows) — Financing0.00.0-0.1
Cash from Financing Activities-92.546.0-29.0
Net Changes in Cash (pre-FX)6.370.5-12.8
Net Changes in Cash6.370.5-12.8
Closing Cash7.7
Reference Items
EBITDA230.6202.3269.0310.3
EBITDA Margin %10.819.7311.6012.30
Free Cash Flow (CFO − Capex)15.9-34.941.341.3
Free Cash Flow to Equity34.641.8
Free Cash Flow per Basic Share0.54-1.191.411.41
Price to Free Cash Flow150.57
Cash Flow to Net Income2.161.771.56
Cash Paid for Taxes42.018.337.9
Cash Paid for Interest16.114.814.5
As filed, sign as filed: a payment tagged as a positive magnitude in the filing stays positive here, so read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown — depth follows the filer, so a thin statement means a thin filing. Total Adjustments is the filer's own grand total of the reconciliation and spans BOTH the non-cash items and the working-capital block; Profit Before Tax plus it equals Cash from Operations (pre-tax). It can be reported when its components are not, so it is never a sum of the rows above it. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.